1. The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole against Colorectal Cancer
   Bo Kang et al, 2022, Cancers CrossRef
2. Alternative Cytotoxic Effects of the Postulated IGF-IR Inhibitor Picropodophyllin In Vitro
   Xuping Wu et al, 2013, Molecular Cancer Therapeutics CrossRef
3. A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial
   Simon Ekman et al, 2016, Acta Oncologica CrossRef
4. Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via Insulin-like growth factor-1 receptor-independent mechanism
   Ahmed Waraky et al, 2014, Oncotarget CrossRef
5. Type I insulin-like growth factor receptor signaling in hematological malignancies
   Deeksha Vishwamitra et al, 2017, Oncotarget CrossRef
6. Picropodophyllin inhibits tumor growth of human nasopharyngeal carcinoma in a mouse model
   Shu-Cheng Yin et al, 2013, Biochemical and Biophysical Research Communications CrossRef
7. Selective elimination of CML stem/progenitor cells by picropodophyllin in vitro and in vivo is associated with p53 activation
   Fenfang Liao et al, 2021, Biochemical and Biophysical Research Communications CrossRef
8. Enhanced function of TRPV1 via up‐regulation by insulin‐like growth factor‐1 in a rat model of bone cancer pain
   Y. Li et al, 2014, European Journal of Pain CrossRef
9. The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link
   Laura W. Bowers et al, 2015, Frontiers in Endocrinology CrossRef
10. Connexin 30 downregulates Insulin-like growth factor receptor-1, abolishes Erk and potentiates effects of an IGF-R inhibitor in a glioma cell line
    Sankaradoss Arun et al, 2016, Brain Research CrossRef
11. Highlights on selected growth factors and their receptors as promising anticancer drug targets
    Mohammed A. Mansour et al, 2021, The International Journal of Biochemistry & Cell Biology CrossRef
12. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells
    Thomas Strömberg et al, 2015, Medical Oncology CrossRef
13. Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma
    Bhawana George et al, 2019, Journal of Hematology & Oncology CrossRef
14. The clinicopathological and prognostic significances of IGF-1R and Livin expression in patients with colorectal cancer
    Zhenling Zhang et al, 2022, BMC Cancer CrossRef
15. Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer
    Pushpendra Singh et al, 2014, Medical Oncology CrossRef
16. MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R
    YINGYING ZHANG et al, 2014, Oncology Reports CrossRef
17. The Insulin-Like Growth Factor-I Receptor Inhibitor Picropodophyllin-Induced Selective Apoptosis of Hepatocellular Carcinoma Cell Through a Caspase-Dependent Mitochondrial Pathway
    Changyong E et al, 2014, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef